- Home
- CLDX vs BHC Comparison
CLDX vs BHC Comparison
Compare CLDX & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLDX | BHC |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.0B |
| IPO Year | 1995 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CLDX | BHC |
|---|---|---|
| Price | $35.26 | $4.79 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 3 |
| Target Price | ★ $46.60 | $8.00 |
| AVG Volume (30 Days) | 913.4K | ★ 2.2M |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ N/A | N/A |
| Revenue | $12,743,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $111.39 | $4.61 |
| Revenue Next Year | $235.85 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 87.78 | N/A |
| 52 Week Low | $19.52 | $4.57 |
| 52 Week High | $35.83 | $8.69 |
Technical Indicators
Market Signals| Indicator | CLDX | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 62.80 | 41.12 |
| Support Level | $28.51 | $4.57 |
| Resistance Level | $35.10 | $6.31 |
| Average True Range (ATR) | 1.23 | 0.28 |
| MACD | 0.43 | 0.01 |
| Stochastic Oscillator | 78.89 | 14.86 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.